...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Additional Exempt Distribution

The question I have is who are these accrediated investor purchaing these notes expecially $ 9 million worth, what do they know going on behind the scenes that us Minions don't know???, Are they  being fed the same garbage rumours we are or something much more credible .... 

Share
New Message
Please login to post a reply